Drug information for SPECTRACEF
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
TABLET; ORAL
200MG
Prescription
CEFDITOREN PIVOXIL
cefditoren pivoxil
VANSEN PHARMA
21222
2009-11-12 Letter
2008-08-05 Letter
2008-07-23 Label
2006-01-19 Letter
2006-01-06 Label
2004-03-28 Letter
2002-08-26 Letter
2002-08-21 Label
2001-12-07 Review
2001-08-29 Letter
2001-08-29 Label
TABLET; ORAL
400MG
Prescription
(Reference Drug)
CEFDITOREN PIVOXIL
cefditoren pivoxil
VANSEN PHARMA
"
Drug Adverse Effects information for SPECTRACEF
Role code
Indications
Reaction
# Reports
PS
PHARYNGOTONSILLITIS
ARTHRITIS
1
PS
PHARYNGOTONSILLITIS
C-REACTIVE PROTEIN INCREASED
1
PS
PHARYNGOTONSILLITIS
ERYTHEMA
1
PS
PHARYNGOTONSILLITIS
PAIN
1
PS
PHARYNGOTONSILLITIS
PRURITUS
1
PS
PHARYNGOTONSILLITIS
PYREXIA
1
PS
PHARYNGOTONSILLITIS
RASH PAPULAR
1
PS
PHARYNGOTONSILLITIS
RED BLOOD CELL SEDIMENTATION RATE INCREASED
1
PS
PHARYNGOTONSILLITIS
SERUM SICKNESS-LIKE REACTION
1
PS
PHARYNGOTONSILLITIS
SWELLING
1
PS
PHARYNGOTONSILLITIS
URTICARIA
1
C
CONTRACEPTION
ABDOMINAL PAIN UPPER
1
C
CONTRACEPTION
CHOLECYSTITIS CHRONIC
3
C
CONTRACEPTION
CHOLELITHIASIS
3
C
CONTRACEPTION
GALLBLADDER DISORDER
3
C
CONTRACEPTION
PAIN
2
C
COUGH
ABDOMINAL PAIN UPPER
2
C
COUGH
CHOLECYSTITIS CHRONIC
2
C
COUGH
CHOLELITHIASIS
2
C
COUGH
GALLBLADDER DISORDER
2
C
HERPES VIRUS INFECTION
ABDOMINAL PAIN UPPER
1
C
HERPES VIRUS INFECTION
CHOLECYSTITIS CHRONIC
1
C
HERPES VIRUS INFECTION
CHOLELITHIASIS
1
C
HERPES VIRUS INFECTION
GALLBLADDER DISORDER
1
C
NASAL CONGESTION
ABDOMINAL PAIN UPPER
3
C
NASAL CONGESTION
CHOLECYSTITIS CHRONIC
3
C
NASAL CONGESTION
CHOLELITHIASIS
3
C
NASAL CONGESTION
GALLBLADDER DISORDER
3
C
PREMENSTRUAL SYNDROME
CHOLECYSTITIS CHRONIC
2
C
PREMENSTRUAL SYNDROME
CHOLELITHIASIS
2
C
PREMENSTRUAL SYNDROME
GALLBLADDER DISORDER
2
C
PREMENSTRUAL SYNDROME
PAIN
2
Ads by Google